ONDRI investigator projects

You are here

ONDRI investigator projects

brain scan side.jpgRead about some of the projects ONDRI's clinicians and researchers are working on outside of ONDRI:

Grant funding helps Baycrest launch pilot project for Canada’s first cross-institutional memory clinic: Drs. Morris Freedman, Stephen Strother, David Tang-Wai

No cure - And few - or no - treatments for these devastating brain diseases: Why not?: Drs. Sandra Black, Lorne Zinman

Study highlights rate of misdiagnosis in Alzheimer's disease patients with psychosis: Dr. Corinne Fischer

uOttawa and Bruyère join forces to fight dementia: Dr. David Park

Dementia fundraising campaign to study memory loss, help people drive longer: Dr. David Park

Massive genome-wide association studies (GWAS) reveals 40 new “intelligence” genes: Dr. Ekaterina Rogaeva

$857,062 grant from Brain Canada's Multi-Investigator Research Initiative: Dr. Doug Munoz

Cognitive and psychosocial function of retired professional hockey players: Dr. Brian Levine

St. Michael’s working on test to diagnose Parkinson’s disease: Dr. David Munoz

Doctors' Notes: For Alzheimer’s researchers, the glass is half full: Dr. Sandra Black

Krembil’s “Mr. Maple Syrup” optimistic about search for Alzheimer’s drugs: Dr. Donald Weaver

CTV News - Bruyère Memory Clinic and Alzheimer's disease: Dr. Andrew Frank

Why do some people develop ALS while others do not? Canada joins international research partnership to find answers and better target the disease - MinE: Dr. Ekaterina Rogaeva

Seniors with memory problems may struggle with driving: Dr. Tom Schweizer

Research led by York improves access to mental health care for immigrants: Dr. Wendy Lou

Stroke patients admitted on weekends may be more likely to die, but don't delay care: Dr. Gustavo Saposnik

Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer: Dr. Connie Marras

Wii games help stroke patients regain lost mobility: Dr. Gustavo Saposnik

Effectiveness of oxytocin (shown to play an important role in social behaviour and empathy) as a possible treatment for patients with frontotemporal dementia: Dr. Elizabeth Finger

Providing a more sensitive measurement of brain function in Alzheimer’s patients using hyperpolarized xenon gas: Dr. Ayman Hassan

Promising findings from the early stages of the clinical trial for “aducanumab” - a human antibody that targets the toxic beta-amyloid protein that clumps together in the brains of Alzheimer’s patients: Dr. Sandra Black

Three ways disruptive technology is combating memory loss: Dr. Angela Troyer

Life after stroke - highlights from the 2016 Canadian Stroke Congress: Dr. Leanne Causabon